Form 4/A for BCDA BioCardia, Inc.
Accepted 2023-08-18 00:00:00 ET · period of report 2023-08-17 · accession 0001437749-23-024141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-08-18 | 2023-08-17 | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | $0.87 | +4,000 | 447.3K | +0.9% | +$3,480 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-17 | P | A | 4,000 | $0.87 | 447,339 | D | — | — | (F1) This transaction was executed in multiple trades ranging from $0.858 to $0.880 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. |